Aaron Cowen serves as Executive at PROKIDNEY CORP., where they oversee executive responsibilities. Since joining the company, Aaron Cowen has executed 12 insider transactions totaling $2.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 29, 2025 involved purchasing 11,587 shares valued at $155.7K.
Aaron Cowen currently holds 1,848,156 shares of PROKIDNEY CORP. (PROK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Cowen has been a net buyer of PROK stock. They have purchased $2.0M and sold $0 worth of shares.
Aaron Cowen's most recent insider trade was on Dec 29, 2025, when they purchased 11,587 shares at $13.44 per share.
Get notified when new Form 4 filings are submitted
| $13.44 |
| Discretionary |
| Dec 26, 2025 | BNTC | $33.0K | Purchase | 2,516 | $13.10 | Discretionary |
| Dec 26, 2025 | BNTC | $187.6K | Purchase | 14,320 | $13.10 | Discretionary |
| Dec 23, 2025 | BNTC | $547.4K | Purchase | 42,600 | $12.85 | Discretionary |
| Dec 23, 2025 | BNTC | $95.1K | Purchase | 7,400 | $12.85 | Discretionary |
| Mar 31, 2023 | PROK | $0 | Other | 3,087,000 | $N/A | Discretionary |
| Mar 31, 2023 | PROK | $0 | Other | 857,500 | $N/A | Discretionary |
| Sep 6, 2022 | PROK | $49.0K | Purchase | 7,007 | $6.99 | Discretionary |
| Aug 31, 2022 | PROK | $18.8K | Purchase | 2,100 | $8.94 | Discretionary |
| Aug 31, 2022 | PROK | $9.5K | Purchase | 1,062 | $8.93 | Discretionary |
| Aug 30, 2022 | PROK | $5.3K | Purchase | 706 | $7.49 | Discretionary |